The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 13, 2018
Filed:
Jul. 17, 2014
Applicant:
Taiho Pharmaceutical Co., Ltd., Chiyoda-ku, Tokyo, JP;
Inventor:
Hiroshi Sootome, Tsukuba, JP;
Assignee:
Taiho Pharmaceutical Co., Ltd., Tokyo, JP;
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/519 (2006.01); A61K 31/437 (2006.01); A61K 31/404 (2006.01); A61K 31/44 (2006.01); A61K 31/47 (2006.01); A61K 31/496 (2006.01); A61K 31/5025 (2006.01); A61K 31/506 (2006.01); A61K 31/53 (2006.01); A61K 31/5377 (2006.01);
U.S. Cl.
CPC ...
A61K 31/519 (2013.01); A61K 31/404 (2013.01); A61K 31/437 (2013.01); A61K 31/44 (2013.01); A61K 31/47 (2013.01); A61K 31/496 (2013.01); A61K 31/506 (2013.01); A61K 31/5025 (2013.01); A61K 31/53 (2013.01); A61K 31/5377 (2013.01);
Abstract
The problem to be solved by the present invention is to provide an anticancer agent for treating tumors resistant to other antitumor agents that inhibit FGFR, and a method for treating such tumors. The present invention provides an antitumor agent for administration to a tumor patient resistant to an FGFR inhibitor, the antitumor agent comprising a 3,5-disubstituted benzene alkynyl compound represented by Formula (I) below or a salt thereof. The present invention also provides a therapeutic method using the anticancer agent.